{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:59:35Z","timestamp":1784667575982,"version":"3.55.0"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T00:00:00Z","timestamp":1399593600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s00431-014-2327-1","type":"journal-article","created":{"date-parts":[[2014,5,8]],"date-time":"2014-05-08T04:21:11Z","timestamp":1399522871000},"page":"1123-1136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["High-mobility group box 1 (HMGB1) in childhood: from bench to bedside"],"prefix":"10.1007","volume":"173","author":[{"given":"Valeria","family":"Chirico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lacquaniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Salpietro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Munaf\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Buemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Arrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Salpietro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,9]]},"reference":[{"key":"2327_CR1","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.4049\/jimmunol.165.6.2950","volume":"165","author":"E Abraham","year":"2000","unstructured":"Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ (2000) HMG-1 as a mediator of acute lung inflammation. J Immunol 165:2950\u20132954","journal-title":"J Immunol"},{"key":"2327_CR2","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/jp.2010.16","volume":"30","author":"ZH Aghai","year":"2010","unstructured":"Aghai ZH, Saslow JG, Meniru C et al (2010) High-mobility group box-1 protein in tracheal aspirates from premature infants: relationship with bronchopulmonary dysplasia and steroid therapy. J Perinatol 30:610\u2013615","journal-title":"J Perinatol"},{"key":"2327_CR3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/cyto.2002.0890","volume":"18","author":"D Agnello","year":"2002","unstructured":"Agnello D, Wang H, Yang H, Tracey KJ, Ghezzi P (2002) HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. Cytokine 18:231\u2013236","journal-title":"Cytokine"},{"key":"2327_CR4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/art.22774","volume":"57","author":"JD Akikusa","year":"2007","unstructured":"Akikusa JD, Schneider R, Harvey EA et al (2007) Clinical features and outcome of pediatric Wegener\u2032s granulomatosis. Arthritis Rheum 57:837\u2013844","journal-title":"Arthritis Rheum"},{"key":"2327_CR5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1757-7241-19-27","volume":"19","author":"Y Albayrak","year":"2011","unstructured":"Albayrak Y, Albayrak A, Celik M et al (2011) High mobility group box protein-1 (HMGB-1) as a new diagnostic marker in patients with acute appendicitis. Scand J Trauma Resusc Emerg Med 19:27","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"2327_CR6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.trstmh.2004.06.008","volume":"99","author":"LM Alleva","year":"2005","unstructured":"Alleva LM, Yang H, Tracy KJ, Clark IA (2005) High mobility group box 1 (HMGB1) protein: possible amplification signal in the pathogenesis. R Soc Trop Med Hyg 99:171\u2013174","journal-title":"R Soc Trop Med Hyg"},{"key":"2327_CR7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1084\/jem.192.4.565","volume":"192","author":"U Andersson","year":"2000","unstructured":"Andersson U, Wang H, Palomblad K et al (2000) High mobility group 1 protein (HMG1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192:565\u2013570","journal-title":"J Exp Med"},{"key":"2327_CR8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1530\/EJE-13-0037","volume":"168","author":"T Arrigo","year":"2013","unstructured":"Arrigo T, Chirico V, Salpietro V et al (2013) High-mobility group protein B1: a new biomarker of metabolic syndrome in obese children. Eur J Endocrinol 168:631\u2013638","journal-title":"Eur J Endocrinol"},{"key":"2327_CR9","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/00207454.2011.580868","volume":"121","author":"T Asano","year":"2011","unstructured":"Asano T, Ichiki K, Koizumi S et al (2011) High mobility group box 1 in cerebrospinal fluid from several neurological diseases at early time points. Int J Neurosci 121:480\u2013484","journal-title":"Int J Neurosci"},{"key":"2327_CR10","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1089\/neu.2011.2171","volume":"29","author":"AK Au","year":"2012","unstructured":"Au AK, Aneja RK, Bell MJ et al (2012) Cerebrospinal fluid levels of high-mobility group box 1 and cytochrome C predict outcome after pediatric traumatic brain injury. J Neurotrauma 29:2013\u20132021","journal-title":"J Neurotrauma"},{"key":"2327_CR11","doi-asserted-by":"crossref","unstructured":"Avalos AM, Kiefer K, Tian J, Christensen S, Shlomchik M, Coyle AJ et al (2010) RAGE-independent autoreactive B cell activation in response to chromatin and HMGB1\/DNA immune complexes. Autoimmunity 43:103--110","DOI":"10.3109\/08916930903384591"},{"key":"2327_CR12","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1542\/peds.2011-3375","volume":"129","author":"RG Bachur","year":"2012","unstructured":"Bachur RG, Hennelly K, Callahan MJ, Chen C, Monuteaux MC (2012) Diagnostic imaging and negative appendectomy rates in children: effects of age and gender. Pediatrics 129:877\u2013884","journal-title":"Pediatrics"},{"key":"2327_CR13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/aur.197","volume":"4","author":"M Barua","year":"2011","unstructured":"Barua M, Jenkins EC, Chen W, Kuizon S, Pullarkat RK, Junaid MA (2011) Glyoxalase I polymorphism rs2736654 causing the Ala111Glu substitution modulates enzyme activity-implications for autism. Autism Res 4:262\u2013270","journal-title":"Autism Res"},{"key":"2327_CR14","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1159\/000316803","volume":"32","author":"RP Berger","year":"2010","unstructured":"Berger RP, Bazaco MC, Wagner AK, Kochanek PM, Fabio A (2010) Trajectory analysis of serum biomarker concentrations facilitates outcome prediction after pediatric traumatic and hypoxemic brain injury. Dev Neurosci 32:396\u2013405","journal-title":"Dev Neurosci"},{"key":"2327_CR15","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s00109-005-0688-7","volume":"83","author":"A Bierhaus","year":"2005","unstructured":"Bierhaus A, Humpert PM, Morcos M et al (2005) Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 83:876\u2013886","journal-title":"J Mol Med"},{"key":"2327_CR16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/emboj\/cdg516","volume":"22","author":"T Bonaldi","year":"2003","unstructured":"Bonaldi T, Talamo F, Scaffidi P et al (2003) Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 22:551\u2013560","journal-title":"EMBO J"},{"key":"2327_CR17","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0733-8619(02)00016-6","volume":"20","author":"DJ Bonthius","year":"2002","unstructured":"Bonthius DJ, Karacay B (2002) Meningitis and encephalitis in children. An update. Neurol Clin 20:1013\u20131038","journal-title":"Neurol Clin"},{"key":"2327_CR18","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1128\/MCB.18.8.4471","volume":"18","author":"V Boonyaratanakornkit","year":"1998","unstructured":"Boonyaratanakornkit V, Melvin V, Prendergast P et al (1998) High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol Cell Biol 18:4471\u20134487","journal-title":"Mol Cell Biol"},{"key":"2327_CR19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nri1132","volume":"3","author":"G Bouma","year":"2003","unstructured":"Bouma G, Strober W (2003) The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3:521\u2013533","journal-title":"Nat Rev Immunol"},{"key":"2327_CR20","doi-asserted-by":"crossref","first-page":"e914","DOI":"10.1542\/peds.2006-0113","volume":"118","author":"D Boyer","year":"2006","unstructured":"Boyer D, Vargas SO, Slattery D, Rivera-Sanchez YM, Colin AA (2006) Churg\u2013Strauss syndrome in children: a clinical and pathologic review. Pediatrics 118:e914\u2013e920","journal-title":"Pediatrics"},{"key":"2327_CR21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/art.23204","volume":"58","author":"HI Brunner","year":"2008","unstructured":"Brunner HI, Gladman DD, Iba\u00f1ez D, Urowitz MD, Silverman ED (2008) Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 58:556\u2013562","journal-title":"Arthritis Rheum"},{"key":"2327_CR22","doi-asserted-by":"crossref","first-page":"958","DOI":"10.2353\/ajpath.2009.090156","volume":"175","author":"CS Buhimschi","year":"2009","unstructured":"Buhimschi CS, Baumbusch MA, Dulay AT et al (2009) Characterization of RAGE, HMGB1, and S100beta in inflammation-induced preterm birth and fetal tissue injury. Am J Pathol 175:958\u2013975","journal-title":"Am J Pathol"},{"key":"2327_CR23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1471-0528.2008.01925.x","volume":"116","author":"CS Buhimschi","year":"2009","unstructured":"Buhimschi CS, Dulay AT, Abdel-Razeq S et al (2009) Fetal inflammatory response in women with proteomic biomarkers characteristic of intra-amniotic inflammation and preterm birth. BJOG 116:257\u2013267","journal-title":"BJOG"},{"key":"2327_CR24","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1128\/MCB.19.8.5237","volume":"19","author":"M Bustin","year":"1999","unstructured":"Bustin M (1999) Regulation of DNA-dependent activities by the functional motifs of the high mobility group chromosomal proteins. Mol Cell Biol 19:5237\u20135246","journal-title":"Mol Cell Biol"},{"key":"2327_CR25","first-page":"E39","volume":"51","author":"M Bustin","year":"2002","unstructured":"Bustin M (2002) At the crossroads of necrosis and apoptosis: signaling to multiple cellular targets by HMGB1. Sci STKE 51:E39","journal-title":"Sci STKE"},{"key":"2327_CR26","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1126\/science.6460317","volume":"215","author":"M Bustin","year":"1982","unstructured":"Bustin M, Reisch J, Einck L, Klippel JH (1982) Autoantibodies to nucleosomal protein; antibodies to HMG-17 in autoimmune disease. Science 215:1245\u20131247","journal-title":"Science"},{"key":"2327_CR27","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1189\/jlb.0908576","volume":"86","author":"L Campana","year":"2009","unstructured":"Campana L, Bosurgi L, Bianchi ME, Manfredi AA, Rovere-Querini P (2009) Requirement of HMGB1 for stromal cell-derived factor-1\/CXCL12-dependent migration of macrophages and dendritic cells. J Leukoc Biol 86:609\u2013615","journal-title":"J Leukoc Biol"},{"key":"2327_CR28","doi-asserted-by":"crossref","first-page":"e6621","DOI":"10.1371\/journal.pone.0006621","volume":"4","author":"ED Carrol","year":"2009","unstructured":"Carrol ED, Mankhambo LA, Jeffers G et al (2009) The diagnostic and prognostic accuracy of five markers of serious bacterial infection in Malawian children with signs of severe infection. PLoS One 4:e6621","journal-title":"PLoS One"},{"key":"2327_CR29","first-page":"393","volume":"17","author":"S Charre","year":"2012","unstructured":"Charre S, Rosmalen JC, Pelegri C et al (2012) Abnormalities in dendritic cell and macrophage accumulation in the pancreas of nonobese diabetic (NOD) mice during the early neonatal period. Histol Histopathol 17:393\u2013401","journal-title":"Histol Histopathol"},{"key":"2327_CR30","doi-asserted-by":"crossref","unstructured":"Chavakis E, Hain A, Vinci M, Carmona G, Bianchi ME, Vajkoczy P et al (2007) High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ Res 100:204--212","DOI":"10.1161\/01.RES.0000257774.55970.f4"},{"key":"2327_CR31","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1194\/jlr.C400018-JLR200","volume":"46","author":"G Chen","year":"2005","unstructured":"Chen G, Li J, Qiang X et al (2005) Suppression of HMGB1 release by stearoyl lysophosphatidylcholine: an additional mechanism for its therapeutic effects in experimental sepsis. J Lipid Res 46:623\u2013627","journal-title":"J Lipid Res"},{"key":"2327_CR32","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1126\/science.1168988","volume":"323","author":"GY Chen","year":"2009","unstructured":"Chen GY, Tang J, Zheng P, Liu Y (2009) CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 323:1722\u20131725","journal-title":"Science"},{"key":"2327_CR33","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/ni.2376","volume":"13","author":"S Chiba","year":"2012","unstructured":"Chiba S, Baghdadi M, Akiba H et al (2012) Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat Immunol 13:832\u2013842","journal-title":"Nat Immunol"},{"key":"2327_CR34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1742-2094-8-135","volume":"8","author":"J Choi","year":"2011","unstructured":"Choi J, Hyun JM, Jeon-Soo S (2011) Increased levels of HMGB1 and pro-inflammatory cytokines in children with febrile seizures. J Neuroinflammation 8:135","journal-title":"J Neuroinflammation"},{"key":"2327_CR35","doi-asserted-by":"crossref","first-page":"e23766","DOI":"10.1371\/journal.pone.0023766","volume":"6","author":"A Ciucci","year":"2011","unstructured":"Ciucci A, Gabriele I, Percario ZA, Affabris E, Colizzi V, Mancino G (2011) HMGB1 and cord blood: its role as immuno-adjuvant factor in innate immunity. PLoS One 6:e23766","journal-title":"PLoS One"},{"key":"2327_CR36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0306-4530(02)00021-5","volume":"28","author":"M Corcos","year":"2003","unstructured":"Corcos M, Guilbaud O, Paterniti S et al (2003) Involvement of cytokines in eating disorders: a critical review of the human literature. Psychoneuroendocrinology 28:229\u2013249","journal-title":"Psychoneuroendocrinology"},{"key":"2327_CR37","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.1093\/emboj\/16.19.5943","volume":"16","author":"E Costello","year":"1997","unstructured":"Costello E, Saudan P, Winocour E, Pizer L, Beard P (1997) High mobility group chromosomal protein 1 binds to the adeno-associated virus replication protein (Rep) and promotes Rep-mediated site-specific cleavage of DNA, ATPase activity and transcriptional repression. EMBO J 16:5943\u20135954","journal-title":"EMBO J"},{"key":"2327_CR38","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00125-009-1394-8","volume":"52","author":"S Devaraj","year":"2009","unstructured":"Devaraj S, Dasu MR, Park SH, Jialal I (2009) Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes. Diabetologia 52:1665\u20131668","journal-title":"Diabetologia"},{"key":"2327_CR39","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jri.2009.09.010","volume":"84","author":"A Dubicke","year":"2010","unstructured":"Dubicke A, Andersson P, Fransson E et al (2010) High-mobility group box protein 1 and its signalling receptors in human preterm and term cervix. J Reprod Immunol 84:86\u201394","journal-title":"J Reprod Immunol"},{"key":"2327_CR40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/INF.0b013e31818ffe60","volume":"28","author":"T Eguchi","year":"2009","unstructured":"Eguchi T, Nomura Y, Hashiguchi T et al (2009) An elevated value of high mobility group box 1 is a potential marker for poor response to high-dose of intravenous immunoglobulin treatment in patients with Kawasaki syndrome. Pediatr Infect Dis J 28:339\u2013341","journal-title":"Pediatr Infect Dis J"},{"key":"2327_CR41","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1158\/1078-0432.CCR-06-1953","volume":"13","author":"JE Ellerman","year":"2007","unstructured":"Ellerman JE, Brown CK, de Vera M et al (2007) Masquerader: high mobility group box-1 and cancer. Clin Cancer Res 13:2836\u20132848","journal-title":"Clin Cancer Res"},{"key":"2327_CR42","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.pnpbp.2010.03.020","volume":"34","author":"E Emanuele","year":"2010","unstructured":"Emanuele E, Boso M, Brondino N et al (2010) Increased serum levels of high mobility group box 1 protein in patients with autistic disorder. Prog Neuropsychopharmacol Biol Psychiatry 34:681\u2013683","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2327_CR43","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbi.2009.08.001","volume":"24","author":"AM Enstrom","year":"2010","unstructured":"Enstrom AM, Onore CE, Van de Water JA, Ashwood P (2010) Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun 24:64\u201371","journal-title":"Brain Behav Immun"},{"key":"2327_CR44","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1242\/jcs.113.4.611","volume":"113","author":"C Fages","year":"2000","unstructured":"Fages C, Nolo R, Huttunen HJ, Eskelinen E, Rauvala H (2000) Regulation of cell migration by amphoterin. J Cell Sci 113:611\u2013620","journal-title":"J Cell Sci"},{"key":"2327_CR45","first-page":"155","volume":"5","author":"HR Ford","year":"1996","unstructured":"Ford HR, Sorrells DL, Knisely AS (1996) Inflammatory cytokines, nitric oxide, and necrotizing enterocolitis. Semin Pediatr Surg 5:155\u2013159","journal-title":"Semin Pediatr Surg"},{"key":"2327_CR46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0952-7915(00)00191-6","volume":"13","author":"S Gallucci","year":"2001","unstructured":"Gallucci S, Matzinger P (2001) Danger signals: SOS to the immune system. Curr Opin Immunol 13:114\u2013119","journal-title":"Curr Opin Immunol"},{"key":"2327_CR47","first-page":"73ra20","volume":"3","author":"GS Garcia-Romo","year":"2011","unstructured":"Garcia-Romo GS, Caielli S, Vega B et al (2011) Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 3:73ra20","journal-title":"Sci Transl Med"},{"key":"2327_CR48","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/978-1-60761-720-4_13","volume":"900","author":"Y Ge","year":"2012","unstructured":"Ge Y, Brown MG, Wang H, Fu SM (2012) Genetic approach to study lupus glomerulonephritis. Methods Mol Biol 900:271\u2013290","journal-title":"Methods Mol Biol"},{"key":"2327_CR49","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1432-1033.1973.tb03026.x","volume":"38","author":"GH Goodwin","year":"1973","unstructured":"Goodwin GH, Sanders C, Johns EW (1973) A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur J Biochem 38:14\u201319","journal-title":"Eur J Biochem"},{"key":"2327_CR50","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/bjs.7395","volume":"8","author":"U G\u00fcller","year":"2011","unstructured":"G\u00fcller U, Rosella L, McCall J, Br\u00fcgger LE, Candinas D (2011) Negative appendicectomy and perforation rates in patients undergoing laparoscopic surgery for suspected appendicitis. Br J Surg 8:589\u2013595","journal-title":"Br J Surg"},{"key":"2327_CR51","doi-asserted-by":"crossref","unstructured":"Hagiwara S, Iwasaka H, Uchino T, Noguchi T (2008) High mobility group box 1 induces a negative inotropic effect on the left ventricle in an isolated rat heart model of septic shock: a pilot study. Circ J 72:1012--1017","DOI":"10.1253\/circj.72.1012"},{"key":"2327_CR52","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1528-1157.1994.tb05932.x","volume":"35","author":"WA Hauser","year":"1994","unstructured":"Hauser WA (1994) The prevalence and incidence of convulsive disorders in children. Epilepsia 35:S1\u2013S6","journal-title":"Epilepsia"},{"key":"2327_CR53","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","volume":"408","author":"H Hemmi","year":"2000","unstructured":"Hemmi H, Takeuchi O, Kawai T et al (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408:740\u2013745","journal-title":"Nature"},{"key":"2327_CR54","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1136\/ard.2010.146456","volume":"70","author":"FO Henes","year":"2011","unstructured":"Henes FO, Chen Y, Bley TA et al (2011) Correlation of serum level of high mobility group box 1 with the burden of granulomatous inflammation in granulomatosis with polyangiitis (Wegener\u2032s). Ann Rheum Dis 70:1926\u20131929","journal-title":"Ann Rheum Dis"},{"key":"2327_CR55","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/03009740802144143","volume":"37","author":"T Hoshina","year":"2008","unstructured":"Hoshina T, Kusuhara K, Ikeda K, Mizuno Y, Saito M, Hara T (2008) High mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) in Kawasaki disease. Scand J Rheumatol 37:445\u2013449","journal-title":"Scand J Rheumatol"},{"key":"2327_CR56","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4161\/auto.8.2.18940","volume":"8","author":"J Huang","year":"2012","unstructured":"Huang J, Liu K, Yu Y et al (2012) Targeting HMGB1-mediated autophagy as a novel therapeutic strategy for osteosarcoma. Autophagy 8:275\u2013277","journal-title":"Autophagy"},{"key":"2327_CR57","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1158\/0008-5472.CAN-11-2001","volume":"72","author":"J Huang","year":"2012","unstructured":"Huang J, Ni J, Liu K et al (2012) HMGB1 promotes drug resistance in osteosarcoma. Cancer Res 72:230\u2013238","journal-title":"Cancer Res"},{"key":"2327_CR58","first-page":"825","volume":"28","author":"T Ito","year":"2008","unstructured":"Ito T, Kawahara K, Okamoto K et al (2008) Proteolytic cleavage of high mobility group box 1 protein by thrombin\u2013thrombomodulin complexes. Arterioscler Thromb Vasc Biol 28:825\u2013830","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2327_CR59","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrclinonc.2011.71","volume":"8","author":"F Janku","year":"2011","unstructured":"Janku F, McConkey DJ, Hong DS, Kurzrock R (2011) Autophagy as a target for anticancer therapy. Nat Rev Clin Oncol 8:528\u2013539","journal-title":"Nat Rev Clin Oncol"},{"key":"2327_CR60","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","volume":"37","author":"JC Jennette","year":"1994","unstructured":"Jennette JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 37:187\u2013192","journal-title":"Arthritis Rheum"},{"key":"2327_CR61","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ajmg.a.30349","volume":"131","author":"MA Junaid","year":"2004","unstructured":"Junaid MA, Kowal D, Barua M, Pullarkat PS, Sklower-Brooks S, Pullarkat RK (2004) Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor. Am J Med Genet A 131:11\u201317","journal-title":"Am J Med Genet A"},{"key":"2327_CR62","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/0961203313519157","volume":"23","author":"F Kanakoudi-Tsakalidou","year":"2014","unstructured":"Kanakoudi-Tsakalidou F, Farmaki E, Tzimouli V et al (2014) Simultaneous changes in serum HMGB1 and IFN-\u03b1 levels and in LAIR-1 expression on plasmatoid dendritic cells of patients with juvenile SLE. New therapeutic options? Lupus 23:305\u2013312","journal-title":"Lupus"},{"key":"2327_CR63","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.4161\/auto.7.10.16753","volume":"7","author":"R Kang","year":"2011","unstructured":"Kang R, Livesey KM, Zeh HJ, Lotze MT, Tang D (2011) Metabolic regulation by HMGB1-mediated autophagy and mitophagy. Autophagy 7:1256\u20131258","journal-title":"Autophagy"},{"key":"2327_CR64","first-page":"329","volume":"45","author":"R Kang","year":"2007","unstructured":"Kang R, Tang DL, Cao LZ, Yu Y, Zhang GY, Xiao XZ (2007) High mobility group box 1 is increased in children with acute lymphocytic leukemia and stimulates the release of tumor necrosis factor-alpha in leukemic cell. Zhonghua Er Ke Za Zhi 45:329\u2013333","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"2327_CR65","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/SHK.0b013e3181a2b886","volume":"32","author":"S Kato","year":"2009","unstructured":"Kato S, Hussein MH, Kakita H et al (2009) Edaravone, a novel free radical scavenger, reduces high-mobility group box 1 and prolongs survival in a neonatal sepsis model. Shock 32:586\u2013592","journal-title":"Shock"},{"key":"2327_CR66","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0889-857X(02)00015-7","volume":"28","author":"M Klein-Gitelman","year":"2002","unstructured":"Klein-Gitelman M, Reiff A, Silverman ED (2002) Systemic lupus erythematosus in childhood. Rheum Dis Clin N Am 28:561\u2013577","journal-title":"Rheum Dis Clin N Am"},{"key":"2327_CR67","first-page":"15","volume":"336","author":"U Koedel","year":"2009","unstructured":"Koedel U (2009) Toll-like receptors in bacterial meningitis. Curr Top Microbiol Immunol 336:15\u201340","journal-title":"Curr Top Microbiol Immunol"},{"key":"2327_CR68","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/art.10540","volume":"46","author":"R Kokkola","year":"2002","unstructured":"Kokkola R, Sundberg E, Ulfgren AK et al (2002) High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum 46:2598\u20132603","journal-title":"Arthritis Rheum"},{"key":"2327_CR69","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3858\/emm.2012.44.4.021","volume":"44","author":"M Li","year":"2012","unstructured":"Li M, Song L, Gao X, Chang W, Qin X (2012) Toll-like receptor 4 on islet \u03b2 cells senses expression changes in high-mobility group box 1 and contributes to the initiation of type 1 diabetes. Exp Mol Med 44:260\u2013267","journal-title":"Exp Mol Med"},{"key":"2327_CR70","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3899\/jrheum.090663","volume":"37","author":"J Li","year":"2010","unstructured":"Li J, Xie H, Wen T, Liu H, Zhu W, Chen X (2010) Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus. J Rheumatol 37:766\u2013775","journal-title":"J Rheumatol"},{"key":"2327_CR71","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1594","volume":"5","author":"MT Lotze","year":"2005","unstructured":"Lotze MT, Tracey KJ (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5:331\u2013342","journal-title":"Nat Rev Immunol"},{"key":"2327_CR72","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.imbio.2009.11.001","volume":"215","author":"ZG Luan","year":"2010","unstructured":"Luan ZG, Zhang H, Yang PT, Ma XC, Zhang C, Guo RX (2010) HMGB1 activates nuclear factor-\u03baB signaling by RAGE and increases the production of TNF-\u03b1 in human umbilical vein endothelial cells. Immunobiology 215:956\u2013962","journal-title":"Immunobiology"},{"key":"2327_CR73","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nm.2127","volume":"16","author":"M Maroso","year":"2010","unstructured":"Maroso M, Balosso S, Ravizza T et al (2010) Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med 16:413\u2013419","journal-title":"Nat Med"},{"key":"2327_CR74","doi-asserted-by":"crossref","unstructured":"Messmer D, Yang H, Telusma G, Knoll F, Li J, Messmer B et al (2004) High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J Immunol 173:307--313","DOI":"10.4049\/jimmunol.173.1.307"},{"key":"2327_CR75","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.4049\/jimmunol.0802994","volume":"183","author":"M Miksa","year":"2009","unstructured":"Miksa M, Wu R, Dong W et al (2009) Immature dendritic cell-derived exosomes rescue septic animals via milk fat globule epidermal growth factor\u2013factor VIII. J Immunol 183:5983\u20135990","journal-title":"J Immunol"},{"key":"2327_CR76","doi-asserted-by":"crossref","first-page":"F208","DOI":"10.1136\/adc.2004.064188","volume":"91","author":"K Mishra","year":"2006","unstructured":"Mishra K, Jacobs SE, Doyle LE, Garland SM (2006) Newer approaches to the diagnosis of early onset neonatal sepsis. Arch Dis Child Fetal Neonatal Ed 91:F208\u2013F212","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2327_CR77","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.pharmthera.2013.11.001","volume":"141","author":"D Musumeci","year":"2014","unstructured":"Musumeci D, Roviello GN, Montesarchio D (2014) An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. Pharmacol Ther 141:347\u2013357","journal-title":"Pharmacol Ther"},{"key":"2327_CR78","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cca.2011.09.035","volume":"413","author":"T Nakamura","year":"2012","unstructured":"Nakamura T, Yamada S, Yoshioka T (2012) Measurement of plasma concentration of high mobility group box1 (HMGB1) in early neonates and evaluation of its usefulness. Clin Chim Acta 413:237\u2013239","journal-title":"Clin Chim Acta"},{"key":"2327_CR79","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1542\/peds.2004-2182","volume":"114","author":"JW Newburger","year":"2004","unstructured":"Newburger JW, Takahashi M, Gerber MA et al (2004) Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114:1708\u20131733","journal-title":"Pediatrics"},{"key":"2327_CR80","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.bbrc.2005.01.021","volume":"328","author":"C Nishitani","year":"2005","unstructured":"Nishitani C, Mitsuzawa H, Hyakushima N, Sano H, Matsushima N, Kuroki Y (2005) The Toll-like receptor 4 region Glu24-Pro34 is critical for interaction with MD-2. Biochem Biophys Res Commun 328:586\u2013590","journal-title":"Biochem Biophys Res Commun"},{"key":"2327_CR81","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(03)12518-4","volume":"361","author":"I Noth","year":"2003","unstructured":"Noth I, Strek ME, Leff AR (2003) Churg\u2013Strauss syndrome. Lancet 361:587\u2013594","journal-title":"Lancet"},{"key":"2327_CR82","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000116635","volume":"94","author":"K Okazaki","year":"2008","unstructured":"Okazaki K, Kondo M, Kato M et al (2008) Elevation of high-mobility group box 1 concentration in asphyxiated neonates. Neonatology 94:105\u2013109","journal-title":"Neonatology"},{"key":"2327_CR83","author":"Y Okuma","year":"2012","unstructured":"Okuma Y, Liu K, Wake H et al (2012) Anti-high mobility group box-1 antibody therapy for traumatic brain injury. Ann Neurol. doi: 10.1002\/ana.23602","journal-title":"Ann Neurol"},{"key":"2327_CR84","first-page":"256","volume":"49","author":"S Ozonoff","year":"2010","unstructured":"Ozonoff S, Iosif AM, Baguio F et al (2010) A prospective study of the emergence of early behavioral signs of autism. J Am Acad Child Adolesc Psychiatry 49:256\u2013266","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2327_CR85","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1083\/jcb.200304135","volume":"164","author":"R Palumbo","year":"2004","unstructured":"Palumbo R, Sampaolesi M, Marchis FD et al (2004) Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J Cell Biol 164:441\u2013449","journal-title":"J Cell Biol"},{"key":"2327_CR86","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1074\/jbc.M306793200","volume":"279","author":"JS Park","year":"2004","unstructured":"Park JS, Svetkauskaite D, He Q et al (2004) Involvement of TLR2 and TRL4 in cellular activation by high mobility group box 1 protein (HMGB1). J Biol Chem 279:7370\u20137376","journal-title":"J Biol Chem"},{"key":"2327_CR87","doi-asserted-by":"crossref","first-page":"16730","DOI":"10.1016\/S0021-9258(18)55362-X","volume":"266","author":"J Parkkinen","year":"1991","unstructured":"Parkkinen J, Rauvala H (1991) Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin. J Biol Chem 266:16730\u201316735","journal-title":"J Biol Chem"},{"key":"2327_CR88","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2334-10-28","volume":"10","author":"J Pavare","year":"2010","unstructured":"Pavare J, Grope I, Kalnins I, Gardovska D (2010) High-mobility group box-1 protein, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in children with community acquired infections and bacteraemia: a prospective study. BMC Infect Dis 10:28","journal-title":"BMC Infect Dis"},{"key":"2327_CR89","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1096\/fj.08-109033","volume":"22","author":"A Raucci","year":"2008","unstructured":"Raucci A, Cugusi S, Antonelli A et al (2008) A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J 22:3716\u20133727","journal-title":"FASEB J"},{"key":"2327_CR90","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1093\/nar\/21.15.3427","volume":"21","author":"CM Read","year":"1993","unstructured":"Read CM, Cary PD, Crane-Robinson C, Driscoll PC, Norman DG (1993) Solution structure of a DNA-binding domain from HMG1. Nucleic Acids Res 21:3427\u20133436","journal-title":"Nucleic Acids Res"},{"key":"2327_CR91","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3109\/14767058.2011.591460","volume":"24","author":"R Romero","year":"2011","unstructured":"Romero R, Chaiworapongsa T, Alpay Savasan Z et al (2011) Damage-associated molecular patterns (DAMPs) in preterm labor with intact membranes and preterm PROM: a study of the alarmin HMGB1. J Matern Fetal Neonatal Med 24:1444\u20131455","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2327_CR92","first-page":"2489","volume":"27","author":"AM Rosenberg","year":"2000","unstructured":"Rosenberg AM, Cordeiro DM (2000) Relationship between sex and antibodies to high mobility group proteins 1 and 2 in juvenile idiopathic arthritis. J Rheumatol 27:2489\u20132493","journal-title":"J Rheumatol"},{"key":"2327_CR93","doi-asserted-by":"crossref","unstructured":"Sakai E, Shimada-Sugawara M, Nishishita K, Fukuma Y, Naito M, Okamoto K et al (2012) Suppression of RANKL-dependent heme oxygenase-1 is required for high mobility group box 1 release and osteoclastogenesis. J Cell Biochem 113:486--498","DOI":"10.1002\/jcb.23372"},{"key":"2327_CR94","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1471-2334-12-112","volume":"12","author":"MS Sanders","year":"2012","unstructured":"Sanders MS, van Well GT, Ouburg S, Morr\u00e9 SA, van Furth AM (2012) Toll-like receptor 9 polymorphisms are associated with severity variables in a cohort of meningococcal meningitis survivors. BMC Infect Dis 12:112","journal-title":"BMC Infect Dis"},{"key":"2327_CR95","doi-asserted-by":"crossref","first-page":"A10","DOI":"10.1136\/annrheumdis-2011-201230.23","volume":"71","author":"H Schierbeck","year":"2012","unstructured":"Schierbeck H, Pullerits R, Pruunsild C et al (2012) Evaluation of the danger signal HMGB1 as a potential biomarker in juvenile idiopathic arthritis (JIA): a preliminary study using the novel biobank jabba. Ann Rheum Dis 71:A10\u2013A11","journal-title":"Ann Rheum Dis"},{"key":"2327_CR96","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.1224989","volume":"337","author":"MW State","year":"2012","unstructured":"State MW, Neuroscience \u0160N (2012) The emerging biology of autism spectrum disorders. Science 337:1301\u20131303","journal-title":"Science"},{"key":"2327_CR97","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1176\/appi.ajp.159.8.1284","volume":"159","author":"HC Steinhausen","year":"2002","unstructured":"Steinhausen HC (2002) The outcome of anorexia nervosa in the 20th century. Am J Psychiatry 159:1284\u20131294","journal-title":"Am J Psychiatry"},{"key":"2327_CR98","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/S0169-409X(02)00160-6","volume":"54","author":"D Stern","year":"2002","unstructured":"Stern D, Yan SD, Yan SF, Schmidt AM (2002) Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv Drug Deliv Rev 54:1615\u20131625","journal-title":"Adv Drug Deliv Rev"},{"key":"2327_CR99","first-page":"807142","volume":"2011","author":"X Su","year":"2011","unstructured":"Su X, Wang H, Zhao J, Pan H, Mao L (2011) Beneficial effects of ethyl pyruvate through inhibiting high-mobility group box 1 expression and TLR4\/NF-\u03baB pathway after traumatic brain injury in the rat. Mediat Inflamm 2011:807142","journal-title":"Mediat Inflamm"},{"key":"2327_CR100","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/35012626","volume":"405","author":"A Taguchi","year":"2000","unstructured":"Taguchi A, Blood DC, del Toro G et al (2000) Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405:354\u2013360","journal-title":"Nature"},{"key":"2327_CR101","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2249.2007.03347.x","volume":"148","author":"T Taira","year":"2007","unstructured":"Taira T, Matsuyama W, Mitsuyama H et al (2007) Increased serum high mobility box-1 level in Churg\u2013Strauss syndrome. Clin Exp Immunol 148:241\u2013247","journal-title":"Clin Exp Immunol"},{"key":"2327_CR102","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.CCM.0000295316.86942.CE","volume":"36","author":"D Tang","year":"2008","unstructured":"Tang D, Kang R, Cao L et al (2008) A pilot study to detect high mobility group box 1 and heat shock protein 72 in cerebrospinal fluid of pediatric patients with meningitis. Crit Care Med 36:291\u2013295","journal-title":"Crit Care Med"},{"key":"2327_CR103","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1600-065X.2012.01146.x","volume":"249","author":"D Tang","year":"2012","unstructured":"Tang D, Kang R, Coyne CB, Zeh HJ, Lotze MT (2012) PAMPs and DAMPs: signal 0\u00a0s that spur autophagy and immunity. Immunol Rev 249:158\u2013175","journal-title":"Immunol Rev"},{"key":"2327_CR104","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/ni1457","volume":"8","author":"J Tian","year":"2007","unstructured":"Tian J, Avalos AM, Mao SY et al (2007) Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8:487\u2013496","journal-title":"Nat Immunol"},{"key":"2327_CR105","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1084\/jem.20081165","volume":"205","author":"V Urbonaviciute","year":"2008","unstructured":"Urbonaviciute V, Furnrohr BG, Meister S et al (2008) Induction of inflammatory and immuneresponses byHMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 205:3007\u20133018","journal-title":"J Exp Med"},{"key":"2327_CR106","first-page":"43","volume":"11","author":"A Vezzani","year":"2010","unstructured":"Vezzani A, Balosso S, Maroso M, Zardoni D, Noe\u2032 F, Ravizza T (2010) ICE\/caspase 1 inhibitors and IL-1beta receptor antagonists as potential therapeutics in epilepsy. Curr Opin Investig Drugs 11:43\u201350","journal-title":"Curr Opin Investig Drugs"},{"key":"2327_CR107","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/j.1528-1167.2005.00298.x","volume":"46","author":"A Vezzani","year":"2005","unstructured":"Vezzani A, Granata T (2005) Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46:1724\u20131743","journal-title":"Epilepsia"},{"key":"2327_CR108","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/ajg.2011.231","volume":"106","author":"R Vitali","year":"2011","unstructured":"Vitali R, Stronati L, Negroni A et al (2011) Fecal HMGB1 is a novel marker of intestinal mucosal inflammation in pediatric inflammatory bowel disease. Am J Gastroenterol 106:2029\u20132040","journal-title":"Am J Gastroenterol"},{"key":"2327_CR109","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0014-5793(80)80453-4","volume":"122","author":"JM Walker","year":"1980","unstructured":"Walker JM, Gooderham K, Hastings JR, Mayes E, Johns EW (1980) The primary structures of non-histone chromosomal proteins HMG1 and 2. FEBS Lett 122:264\u2013270","journal-title":"FEBS Lett"},{"key":"2327_CR110","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.cca.2012.07.002","volume":"413","author":"KY Wang","year":"2012","unstructured":"Wang KY, Yu GF, Zhang ZY, Huang Q, Dong WQ (2012) Plasma high-mobility group box 1 levels and prediction of outcome in patients with traumatic brain injury. Clin Chim Acta 413:1737\u20131741","journal-title":"Clin Chim Acta"},{"key":"2327_CR111","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.PCC.0000161289.22464.C3","volume":"6","author":"RS Watson","year":"2005","unstructured":"Watson RS, Carcillo JA (2005) Scope and epidemiology of pediatric sepsis. Pediatr Crit Care 6:3\u20134","journal-title":"Pediatr Crit Care"},{"key":"2327_CR112","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1136\/ard.2009.119172","volume":"69","author":"D Wibisono","year":"2010","unstructured":"Wibisono D, Csernok E, Lamprecht P, Holle JU, Gross WL, Moosig F (2010) Serum HMGB1 levels are increased in active Wegener\u2019s granulomatosis and differentiate between active forms of ANCA-associated vasculitis. Ann Rheum Dis 69:1888\u20131889","journal-title":"Ann Rheum Dis"},{"key":"2327_CR113","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/art.1780330910","volume":"33","author":"B Wittemann","year":"1990","unstructured":"Wittemann B, Neuer G, Michels H, Truckenbrodt H, Bautz FA (1990) Autoantibodies to nonhistone chromosomal proteins HMG-1 and HMG-2 in sera of patients with juvenile rheumatoid arthritis. Arthritis Rheum 33:1378\u20131383","journal-title":"Arthritis Rheum"},{"key":"2327_CR114","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pedneo.2012.04.001","volume":"53","author":"SF Wu","year":"2012","unstructured":"Wu SF, Caplan M, Lin HC (2012) Necrotizing enterocolitis: old problem with new hope. Pediatr Neonatol 53:158\u2013163","journal-title":"Pediatr Neonatol"},{"key":"2327_CR115","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1757-7241-20-61","volume":"20","author":"C Wu","year":"2012","unstructured":"Wu C, Sun H, Wang H et al (2012) Evaluation of high mobility group box 1 protein as a presurgical diagnostic marker reflecting the severity of acute appendicitis. Scand J Trauma Resusc Emerg Med 20:61","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"2327_CR116","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1073\/pnas.2434651100","volume":"101","author":"H Yang","year":"2004","unstructured":"Yang H, Ochani M, Li J et al (2004) Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A 101:296\u2013301","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2327_CR117","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3109\/10428194.2011.616962","volume":"53","author":"L Yang","year":"2012","unstructured":"Yang L, Yu Y, Kang R et al (2012) Up-regulated autophagy by endogenous high mobility group box-1 promotes chemoresistance in leukemia cells. Leuk Lymphoma 53:315\u2013322","journal-title":"Leuk Lymphoma"},{"key":"2327_CR118","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/sj.mp.4002050","volume":"12","author":"D Yasuhara","year":"2007","unstructured":"Yasuhara D, Hashiguchi T, Kawahara K et al (2007) High mobility group box 1 and refeeding-resistance in anorexia nervosa. Mol Psychiatry 12:976\u2013977","journal-title":"Mol Psychiatry"},{"key":"2327_CR119","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1093\/nar\/20.13.3516","volume":"20","author":"WV Yotov","year":"1992","unstructured":"Yotov WV, St-Arnaud R (1992) Nucleotide sequence of a mouse cDNA encoding the nonhistonne chromosomal high mobility group protein-1 (HMG1). Nucleic Acids Res 20:3516","journal-title":"Nucleic Acids Res"},{"key":"2327_CR120","doi-asserted-by":"crossref","first-page":"91R","DOI":"10.1203\/PDR.0b013e31819dba7d","volume":"65","author":"C Young","year":"2009","unstructured":"Young C, Sharma R, Handfield M, Mai V, Neu J (2009) Biomarkers for infants at risk for necrotizing enterocolitis: clues to prevention? Pediatr Res 65:91R\u201397R","journal-title":"Pediatr Res"},{"key":"2327_CR121","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/01.shk.0000225404.51320.82","volume":"26","author":"M Yu","year":"2006","unstructured":"Yu M, Wang H, Ding A et al (2006) HMGB1 signals through Toll-like receptor (TLR) 4 and TLR 2. Shock 26:174\u2013179","journal-title":"Shock"},{"key":"2327_CR122","doi-asserted-by":"crossref","first-page":"G643","DOI":"10.1152\/ajpgi.00181.2005","volume":"289","author":"R Zamora","year":"2005","unstructured":"Zamora R, Grishin A, Wong C et al (2005) High-mobility group box 1 protein is an inflammatory mediator in necrotizing enterocolitis: protective effect of the macrophage deactivator semapimod. Am J Physiol Gastrointest Liver Physiol 289:G643\u2013G652","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2327_CR123","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1203\/00006450-200208000-00004","volume":"52","author":"CK Zetterstrom","year":"2002","unstructured":"Zetterstrom CK, Bergman T, Rynnel-Dag\u00f6\u00f6 B et al (2002) High mobility group box chromosomal protein 1 (HMGB1) is an antibacterial factor produced by the human adenoid. Pediatr Res 52:148\u2013154","journal-title":"Pediatr Res"},{"key":"2327_CR124","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/brain\/awr032","volume":"134","author":"E Zurolo","year":"2011","unstructured":"Zurolo E, Iyer A, Maroso M et al (2011) Activation of toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development. Brain 134:1015\u20131032","journal-title":"Brain"},{"key":"2327_CR125","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.semarthrit.2008.05.004","volume":"39","author":"J Zwerina","year":"2009","unstructured":"Zwerina J, Eger G, Englbrecht M, Manger B, Schett G (2009) Churg\u2013Strauss syndrome in childhood: a systematic literature review and clinical comparison with adult patients. Semin Arthritis Rheum 39:108\u2013115","journal-title":"Semin Arthritis Rheum"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-014-2327-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-014-2327-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-014-2327-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T23:18:32Z","timestamp":1689203912000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-014-2327-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,9]]},"references-count":125,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["2327"],"URL":"https:\/\/doi.org\/10.1007\/s00431-014-2327-1","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,9]]}}}